A subset of AD patients (n = 12) was clinically asked to undergo lumbar puncture to ascertain diagnosis using CSF biomarkers, including Aβ42/Aβ40 ratio, phosphorylated tau (p-tau), and the p-tau/Aβ42 ratio (see Table S1 in the supplemental material). Here, MAPT is linked to Alzheimer disease.